Befunolol
SENSORY ORGANS
Also known as: befunolol HCl, befunolol hydrochloride, bentos
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Befunolol is a drug catalogued in DrugCentral. Recorded indications include Ocular hypertension and Open-angle glaucoma.
- Indications: Ocular hypertension and Open-angle glaucoma.
- ATC code: S01ED06 (Beta blocking agents).
- Molecular formula: C16H21NO4; molecular weight 291.35 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Ocular hypertension
- Open-angle glaucoma
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
S01ED06 | SENSORY ORGANS › OPHTHALMOLOGICALS › ANTIGLAUCOMA PREPARATIONS AND MIOTICS › Beta blocking agents |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Befunolol is on its molecule page.
| Molecular formula | C16H21NO4 |
|---|---|
| Molecular weight | 291.35 g/mol |
| CAS number | 39552-01-7 |
| InChIKey | ZPQPDBIHYCBNIG-UHFFFAOYSA-N |
| PubChem CID | 2309 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Befunolol used for?
DrugCentral lists the following indications for Befunolol: Ocular hypertension and Open-angle glaucoma.
What is the chemical formula of Befunolol?
Befunolol has the molecular formula C16H21NO4 and a molecular weight of 291.35 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 295 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL153984 — compound record and bioactivity
- PubChem CID 2309 — chemical identifiers
- DrugBank DB09013 — drug record
- FDA UNII 418546MT3A — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.